Works matching IS 08876924 AND DT 2006 AND VI 20 AND IP 3

Results: 36

Target for cancer therapy: proliferating cells or stem cells.

Published in:

Leukemia (08876924), 2006, v. 20, n. 3, p. 385, doi. 10.1038/sj.leu.2404075

By:

Blagosklonny, M. V.

Publication type:

Article

Population-based demographic study of karyotypes in 1709 patients with adult Acute Myeloid Leukemia.

Published in:

Leukemia (08876924), 2006, v. 20, n. 3, p. 444, doi. 10.1038/sj.leu.2404055

By:

Sanderson, R. N.;
Johnson, P. R. E.;
Moorman, A. V.;
Roman, E.;
Willett, E.;
Taylor, P. R.;
Proctor, S. J.;
Bown, N.;
Ogston, S.;
Bowen, D. T.

Publication type:

Article

Activating mutations of JAK2V617F are uncommon in t-MDS and t-AML and are only observed in atypic cases.

Published in:

Leukemia (08876924), 2006, v. 20, n. 3, p. 547, doi. 10.1038/sj.leu.2404072

By:

Desta, F.;
Christiansen, D. H.;
Andersen, M. K.;
Pedersen-Bjergaard, J.

Publication type:

Article

High Mda-7 expression promotes malignant cell survival and p38 MAP kinase activation in chronic lymphocytic leukemia.

Published in:

Leukemia (08876924), 2006, v. 20, n. 3, p. 498, doi. 10.1038/sj.leu.2404073

By:

Sainz-Perez, A.;
Gary-Gouy, H.;
Portier, A.;
Davi, F.;
Merle-Beral, H.;
Galanaud, P.;
Dalloul, A.

Publication type:

Article

Increase of CCR7− CD45RA+ CD8 T cells (TEMRA) in chronic graft-versus-host disease.

Published in:

Leukemia (08876924), 2006, v. 20, n. 3, p. 545, doi. 10.1038/sj.leu.2404079

By:

D'Asaro, M.;
Dieli, F.;
Caccamo, N.;
Musso, M.;
Porretto, F.;
Salerno, A.

Publication type:

Article

Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes.

Published in:

Leukemia (08876924), 2006, v. 20, n. 3, p. 463, doi. 10.1038/sj.leu.2404080

By:

Kiladjian, J.-J.;
Bourgeois, E.;
Lobe, I.;
Braun, T.;
Visentin, G.;
Bourhis, J.-H.;
Fenaux, P.;
Chouaib, S.;
Caignard, A.

Publication type:

Article

JAK2 V617F mutation in classic chronic myeloproliferative diseases: a report on a series of 349 patients.

Published in:

Leukemia (08876924), 2006, v. 20, n. 3, p. 534, doi. 10.1038/sj.leu.2404086

By:

Vizmanos, J. L.;
Ormazábal, C.;
Larráyoz, M. J.;
Cross, N. C. P.;
Calasanz, M. J.

Publication type:

Article

CD49d in B-cell chronic lymphocytic leukemia: correlated expression with CD38 and prognostic relevance.

Published in:

2006

By:

Zucchetto, A.;
Bomben, R.;
Dal Bo, M.;
Bulian, P.;
Benedetti, D.;
Nanni, P.;
del Poeta, G.;
Degan, M.;
Gattei, V.

Publication type:

Letter

Reply to Pittner et al.

Published in:

2006

By:

Zucchetto, A.;
Bomben, R.;
Dal Bo, M.;
Bulian, P.;
Benedetti, D.;
Nanni, P.;
del Poeta, G.;
Degan, M.;
Gattei, V.

Publication type:

Letter

JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders.

Published in:

Leukemia (08876924), 2006, v. 20, n. 3, p. 471, doi. 10.1038/sj.leu.2404081

By:

Quentmeier, H.;
MacLeod, R. A. F.;
Zaborski, M.;
Drexler, H. G.

Publication type:

Article

Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patients.

Published in:

Leukemia (08876924), 2006, v. 20, n. 3, p. 542, doi. 10.1038/sj.leu.2404085

By:

Pérez-Simón, J. A.;
Sureda, A.;
Fernández-Aviles, F.;
Sampol, A.;
Cabrera, J. R.;
Caballero, D.;
Martino, R.;
Petit, J.;
Tomás, J. F.;
Moraleda, J. M.;
Alegre, A.;
Cañizo, C.;
Brunet, S.;
Rosiñol, L.;
Lahuerta, J.;
Díez-Martín, J. L.;
León, A.;
García, A.;
Vazquez, L.;
Sierra, J.

Publication type:

Article

Reply to ‘CD49d in B-cell chronic lymphocytic leukemia: correlated expression with CD38 and prognostic relevance’ by Zucchetto et al.

Published in:

Leukemia (08876924), 2006, v. 20, n. 3, p. 528, doi. 10.1038/sj.leu.2404088

By:

Pittner, B. T.;
Shanafelt, T. D.;
Kay, N. E.;
Jelinek, D. F.

Publication type:

Article

Monitoring minimal residual disease by quantification of genomic chromosomal breakpoint sequences in acute leukemias with MLL aberrations.

Published in:

2006

By:

Burmeister, T.;
Marschalek, R.;
Schneider, B.;
Meyer, C.;
Gökbuget, N.;
Schwartz, S.;
Hoelzer, D.;
Thiel, E.;
Gökbuget, N

Publication type:

journal article

Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(12;21)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome.

Published in:

Leukemia (08876924), 2006, v. 20, n. 3, p. 410, doi. 10.1038/sj.leu.2404083

By:

Stams, W. A. G.;
Beverloo, H. B.;
den Boer, M. L.;
de Menezes, R. X.;
Stigter, R. L.;
van Drunen, E.;
Ramakers-van-Woerden, N. L.;
Loonen, A. H.;
van Wering, E. R.;
Janka-Schaub, G. E.;
Pieters, R.

Publication type:

Article

Caspase-dependent and -independent cell death of Jurkat human leukemia cells induced by novel synthetic ceramide analogs.

Published in:

Leukemia (08876924), 2006, v. 20, n. 3, p. 392, doi. 10.1038/sj.leu.2404084

By:

Granot, T.;
Milhas, D.;
Carpentier, S.;
Dagan, A.;
Ségui, B.;
Gatt, S.;
Levade, T.

Publication type:

Article

Long-term survival data from a phase 3 study of Filgrastim as an adjunct to chemotherapy in adults with de novo acute myeloid leukemia.

Published in:

Leukemia (08876924), 2006, v. 20, n. 3, p. 404, doi. 10.1038/sj.leu.2404090

By:

Heil, G.;
Hoelzer, D.;
Sanz, M. A.;
Lechner, K.;
Noens, L.;
Szer, J.;
Ganser, A.;
Matcham, J.;
Renwick, J.

Publication type:

Article

ATM variants and predisposition to childhood T-lineage acute lymphoblastic leukaemia.

Published in:

Leukemia (08876924), 2006, v. 20, n. 3, p. 526, doi. 10.1038/sj.leu.2404091

By:

Gumy-Pause, F.;
Wacker, P.;
Maillet, P.;
Betts, D. R.;
Sappino, A.-P.

Publication type:

Article

Reply to ‘ATM variants and predisposition to childhood T-lineage acute lymphoblastic leukaemia’ by Gumy-Pause et al.

Published in:

2006

By:

Meier, M.;
den Boer, M. L.;
Hall, A. G.;
Irving, J. A. E.;
Passier, M.;
Minto, L.;
van Wering, E. R.;
Janka-Schaub, G. E.;
Pieters, R.

Publication type:

Letter

Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemia.

Published in:

Leukemia (08876924), 2006, v. 20, n. 3, p. 437, doi. 10.1038/sj.leu.2404093

By:

Ritter, M.;
Kattmann, D.;
Teichler, S.;
Hartmann, O.;
Samuelsson, M. K. R.;
Burchert, A.;
Bach, J.-P.;
Kim, T. D.;
Berwanger, B.;
Thiede, C.;
Jäger, R.;
Ehninger, G.;
Schäfer, H.;
Ueki, N.;
Hayman, M. J.;
Eilers, M.;
Neubauer, A.

Publication type:

Article

Low or absent SPARC expression in acute myeloid leukemia with MLL rearrangements is associated with sensitivity to growth inhibition by exogenous SPARC protein.

Published in:

2006

By:

DiMartino, J. F.;
Lacayo, N. J.;
Varadi, M.;
Li, L.;
Saraiya, C.;
Ravindranath, Y.;
Yu, R.;
Sikic, B. I.;
Raimondi, S. C.;
Dahl, G. V.

Publication type:

journal article

A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma.

Published in:

Leukemia (08876924), 2006, v. 20, n. 3, p. 536, doi. 10.1038/sj.leu.2404104

By:

Adélaïde, J.;
Pérot, C.;
Gelsi-Boyer, V.;
Pautas, C.;
Murati, A.;
Copie-Bergman, C.;
Imbert, M.;
Chaffanet, M.;
Birnbaum, D.;
Mozziconacci, M.-J.

Publication type:

Article

Gain of chromosome 6p is an infrequent cause of increased PIM1 expression in B-cell non-Hodgkin's lymphomas.

Published in:

Leukemia (08876924), 2006, v. 20, n. 3, p. 539, doi. 10.1038/sj.leu.2404094

By:

Sivertsen, E. A.;
Galteland, E.;
Mu, D.;
Holte, H.;
Meza-Zepeda, L.;
Myklebost, O.;
Patzke, S.;
Smeland, E. B.;
Stokke, T.

Publication type:

Article

The GATA site-dependent hemogen promoter is transcriptionally regulated by GATA1 in hematopoietic and leukemia cells.

Published in:

Leukemia (08876924), 2006, v. 20, n. 3, p. 417, doi. 10.1038/sj.leu.2404105

By:

Yang, L. V.;
Wan, J.;
Ge, Y.;
Fu, Z.;
Kim, S. Y.;
Fujiwara, Y.;
Taub, J. W.;
Matherly, L. H.;
Eliason, J.;
Li, L.

Publication type:

Article

Pro-apoptotic properties of hyperforin in leukemic cells from patients with B-cell chronic lymphocytic leukemia.

Published in:

2006

By:

Quiney, C.;
Billard, C.;
Faussat, A. M.;
Salanoubat, C.;
Ensaf, A.;
Naït-Si, Y.;
Fourneron, J. D.;
Kolb, J.-P.;
Naït-Si, Y

Publication type:

journal article

High incidence of Notch-1 mutations in adult patients with T-cell acute lymphoblastic leukemia.

Published in:

2006

By:

Mansour, M. R.;
Linch, D. C.;
Foroni, L.;
Goldstone, A. H.;
Gale, R. E.

Publication type:

Letter

Universal N-glycosylation sites introduced into the B-cell receptor of follicular lymphoma by somatic mutation: a second tumorigenic event?

Published in:

Leukemia (08876924), 2006, v. 20, n. 3, p. 530, doi. 10.1038/sj.leu.2404095

By:

McCann, K. J.;
Johnson, P. W. M.;
Stevenson, F. K.;
Ottensmeier, C. H.

Publication type:

Article

Cooperation of activating Ras/rtk signal transduction pathway mutations and inactivating myeloid differentiation gene mutations in M0 AML: a study of 45 patients.

Published in:

Leukemia (08876924), 2006, v. 20, n. 3, p. 433, doi. 10.1038/sj.leu.2404097

By:

Roumier, C.;
Lejeune-Dumoulin, S.;
Renneville, A.;
Goethgeluck, A. S.;
Philippe, N.;
Fenaux, P.;
Preudhomme, C.

Publication type:

Article

Chromosomal change during 6-mercaptopurine (6-MP) therapy in juvenile myelomonocytic leukemia: the growth of a 6-MP-refractory clone that already exists at onset.

Published in:

Leukemia (08876924), 2006, v. 20, n. 3, p. 485, doi. 10.1038/sj.leu.2404106

By:

Matsuda, K.;
Matsuzaki, S.;
Miki, J.;
Hidaka, E.;
Yanagisawa, R.;
Nakazawa, Y.;
Sakashita, K.;
Kamijo, T.;
Asami, K.;
Sano, K.;
Koike, K.

Publication type:

Article

Cytogenetic response to prior treatment with interferon-α is predictive for survival after allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemia.

Published in:

Leukemia (08876924), 2006, v. 20, n. 3, p. 477, doi. 10.1038/sj.leu.2404100

By:

Maywald, O.;
Pfirrmann, M.;
Berger, U.;
Breitscheidel, L.;
Gratwohl, A.;
Kolb, H.-J.;
Beelen, D. W.;
Tobler, A.;
Metzgeroth, G.;
Gnad, S. U.;
Hochhaus, A.;
Hasford, J.;
Hehlmann, R.;
Reiter, A.

Publication type:

Article

Reply to Herens et al.

Published in:

2006

By:

Lo Vasco, V. R.;
Follo, M. Y.;
Cocco, L.

Publication type:

Letter

Inositide-specific phospholipase c β1 gene deletion is a rare event in myelodysplastic syndromes.

Published in:

2006

By:

Herens, C.;
Ketelslegers, O.;
Tassin, F.;
Hansen, S.;
Bours, V.

Publication type:

Letter

Reply to Lo Vasco et al.

Published in:

2006

By:

Herens, C.;
Ketelslegers, O.;
Tassin, F.;
Hansen, S.;
Bours, V.

Publication type:

Letter

TCRγδ+ large granular lymphocyte leukemias reflect the spectrum of normal antigen-selected TCRγδ+ T-cells.

Published in:

Leukemia (08876924), 2006, v. 20, n. 3, p. 505, doi. 10.1038/sj.leu.2404112

By:

Sandberg, Y.;
Almeida, J.;
Gonzalez, M.;
Lima, M.;
Bárcena, P.;
Szczepañski, T.;
van Gastel-Mol, E. J.;
Wind, H.;
Balanzategui, A.;
van Dongen, J. J. M.;
Miguel, J. F. San;
Orfao, A.;
Langerak, A. W.

Publication type:

Article

Mechanisms of apoptosis-induction by rottlerin: therapeutic implications for B-CLL.

Published in:

Leukemia (08876924), 2006, v. 20, n. 3, p. 514, doi. 10.1038/sj.leu.2404113

By:

Ringshausen, I.;
Oelsner, M.;
Weick, K.;
Bogner, C.;
Peschel, C.;
Decker, T.

Publication type:

Article

High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia.

Published in:

Leukemia (08876924), 2006, v. 20, n. 3, p. 400, doi. 10.1038/sj.leu.2404115

By:

D. Rea;
Legros, L.;
Raffoux, E.;
Thomas, X.;
Turlure, P.;
Maury, S.;
Dupriez, B.;
Pigneux, A.;
Choufi, B.;
Reman, O.;
Stéphane, D.;
Royer, B.;
Vigier, M.;
Ojeda-Uribe, M.;
Recher, C.;
Dombret, H.;
Huguet, F.;
Rousselot, P.

Publication type:

Article

Quantitative analysis of bone marrow CD34 cells in aplastic anemia and hypoplastic myelodysplastic syndromes.

Published in:

Leukemia (08876924), 2006, v. 20, n. 3, p. 458, doi. 10.1038/sj.leu.2404119

By:

Matsui, W. H.;
Brodsky, R. A.;
Smith, B. D.;
Borowitz, M. J.;
Jones, R. J.

Publication type:

Article

Works matching IS 08876924 AND DT 2006 AND VI 20 AND IP 3

Target for cancer therapy: proliferating cells or stem cells.

Population-based demographic study of karyotypes in 1709 patients with adult Acute Myeloid Leukemia.

Activating mutations of JAK2V617F are uncommon in t-MDS and t-AML and are only observed in atypic cases.

High Mda-7 expression promotes malignant cell survival and p38 MAP kinase activation in chronic lymphocytic leukemia.

Increase of CCR7<sup>−</sup> CD45RA<sup>+</sup> CD8 T cells (T<sub>EMRA</sub>) in chronic graft-versus-host disease.

Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes.

JAK2 V617F mutation in classic chronic myeloproliferative diseases: a report on a series of 349 patients.

CD49d in B-cell chronic lymphocytic leukemia: correlated expression with CD38 and prognostic relevance.

Reply to Pittner et al.

JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders.

Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patients.

Reply to ‘CD49d in B-cell chronic lymphocytic leukemia: correlated expression with CD38 and prognostic relevance’ by Zucchetto et al.

Monitoring minimal residual disease by quantification of genomic chromosomal breakpoint sequences in acute leukemias with MLL aberrations.

Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(12;21)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome.

Caspase-dependent and -independent cell death of Jurkat human leukemia cells induced by novel synthetic ceramide analogs.

Long-term survival data from a phase 3 study of Filgrastim as an adjunct to chemotherapy in adults with de novo acute myeloid leukemia.

ATM variants and predisposition to childhood T-lineage acute lymphoblastic leukaemia.

Reply to ‘ATM variants and predisposition to childhood T-lineage acute lymphoblastic leukaemia’ by Gumy-Pause et al.

Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemia.

Low or absent SPARC expression in acute myeloid leukemia with MLL rearrangements is associated with sensitivity to growth inhibition by exogenous SPARC protein.

A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma.

Gain of chromosome 6p is an infrequent cause of increased PIM1 expression in B-cell non-Hodgkin's lymphomas.

The GATA site-dependent hemogen promoter is transcriptionally regulated by GATA1 in hematopoietic and leukemia cells.

Pro-apoptotic properties of hyperforin in leukemic cells from patients with B-cell chronic lymphocytic leukemia.

High incidence of Notch-1 mutations in adult patients with T-cell acute lymphoblastic leukemia.

Universal N-glycosylation sites introduced into the B-cell receptor of follicular lymphoma by somatic mutation: a second tumorigenic event?

Cooperation of activating Ras/rtk signal transduction pathway mutations and inactivating myeloid differentiation gene mutations in M0 AML: a study of 45 patients.

Chromosomal change during 6-mercaptopurine (6-MP) therapy in juvenile myelomonocytic leukemia: the growth of a 6-MP-refractory clone that already exists at onset.

Cytogenetic response to prior treatment with interferon-α is predictive for survival after allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemia.

Reply to Herens et al.

Inositide-specific phospholipase c β1 gene deletion is a rare event in myelodysplastic syndromes.

Reply to Lo Vasco et al.

TCRγδ<sup>+</sup> large granular lymphocyte leukemias reflect the spectrum of normal antigen-selected TCRγδ<sup>+</sup> T-cells.

Mechanisms of apoptosis-induction by rottlerin: therapeutic implications for B-CLL.

High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia.

Quantitative analysis of bone marrow CD34 cells in aplastic anemia and hypoplastic myelodysplastic syndromes.